Skip to main content

Table 11 Calculation of incremental cost effectiveness ratio

From: Economic evaluation of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital-Cameroon: a cost analysis

Treatment alternative Cost ($) Effect (PRR24) Incremental cost ($) Incremental effect (PRR24) ICER ($ per PRR24) Comment
QLD 51.45 0.8384     Baseline (B)
QNLD2 52.88 0.7987 1.43 −0.0397 36.020 Extended dominated
ARTES 57.85 0.9752 4.97 0.1765 28.159 Comparator (A)
QNLD3 58.18 0.7543 0.33    Dominated
  1. \(ICER = \frac{{{\text{Cost}} {\text{A}} - {\text{Cost}} {\text{B}}}}{{{\text{Effect A}} - {\text{Effect}} {\text{B}}}} = \frac{57.85 - 51.45}{0.9752 - 0.8384} = \frac{6.4}{0.1368} = \, 46.78\$ /{\text{PRR}}_{24}\)